Wow! What a day!! DNDN roller coaster, swine flu, Pfizer (PFE) earnings, it was crazy! Let’s get to it…

Dendreon

• First, DNDN presented strong data at AUA today, the moment everyone was waiting for. Check it out here –> [WSJ]

• Next, the stock took a wild ride, which we profiled all day. [IguanaBio]

• The WSJ Health Blog also did a take before the after-hours trading. [WSJ Health Blog]

• Finally, investors who sold on the way down lost tons as the stock resumed trading and skyrocketed after-hours. [Bloomberg]

Swine Flu

• Some drugmakers stayed up (eg Biocryst), but others like Hemispherx Biopharma and Generex fell back down as panic settled in the markets. [TransWorldNews]

• California Gov. Arnold Swarzenegger declared a State of Emergency over the swine flu outbreak. [Bloomberg]

• Bogus online pharmacies are trying to harvest credit card details by offering ‘anti-flu’ drugs. [TimesOnline]

• The FDA has allowed off-label use of anti-flu meds. [FiercePharma]

Other News, Money and Drugs

• The FDA has yet again delayed a ruling on United Therapeutics’ inhaled Remodulin from April 30th to July 30th. [BizJournals]

• Pfizer’s net income fell 2% while the company’s biotech chief abruptly resigns. [WSJ health Blog]

• The Pfizer biotech head who left, Corey Goodman, signed a $1.7M vow of silence, forever. [BNET Pharma]

• Novo Nordisk has postponed pre-launch physician training for liraglutide. Hmmm… [Financial Times]

• Johns Hopkins wants to screen a library of compounds for new disease. Hopefully someone there knows about the market and something called patents. [New York Times]

• Cephalon says a patient on Treanda (bendamustine) has died of fatal skin rash, Stevens Johnson Syndrome. [Reuters]

• Finally, Genaera Corporation will enter The Graveyard and liquidate itself. [Pharmalive]

Image from nytimes

Related Posts